ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 51 filers reported holding ELOXX PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $99,000 | -25.6% | 29,764 | -10.8% | 0.00% | – |
| Q4 2020 | $133,000 | +82.2% | 33,364 | +20.0% | 0.00% | – |
| Q3 2020 | $73,000 | -28.4% | 27,814 | -17.7% | 0.00% | – |
| Q2 2020 | $102,000 | +72.9% | 33,809 | +12.1% | 0.00% | – |
| Q1 2020 | $59,000 | -73.7% | 30,151 | -1.1% | 0.00% | – |
| Q4 2019 | $224,000 | +64.7% | 30,476 | +1.0% | 0.00% | – |
| Q3 2019 | $136,000 | -53.6% | 30,186 | +2.7% | 0.00% | -100.0% |
| Q2 2019 | $293,000 | -9.3% | 29,394 | +6.2% | 0.00% | 0.0% |
| Q1 2019 | $323,000 | -5.8% | 27,675 | -3.1% | 0.00% | 0.0% |
| Q4 2018 | $343,000 | +6.9% | 28,562 | +51.5% | 0.00% | 0.0% |
| Q3 2018 | $321,000 | -4.7% | 18,855 | -4.5% | 0.00% | 0.0% |
| Q2 2018 | $337,000 | – | 19,750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|